Company news
Trisalus Life Sciences, Inc. (NASDAQ:TLSI) news
Every Trisalus Life Sciences, Inc. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
TriSalus Life Sciences Reports Second Quarter 2026 Results
August 6, 2026
TriSalus Life Sciences to Participate in the Canaccord Genuity 46th Annual Growth Conference
July 29, 2026
TriSalus Life Sciences to Host Second Quarter 2026 Financial Results Conference Call
July 16, 2026
TriSalus Life Sciences to Host Virtual KOL Event on June 24 Featuring New Real-World Evidence for Pressure-Enabled Drug Delivery™ in Live...
June 10, 2026
TriSalus Life Sciences Reports First Quarter 2026 Results Demonstrating Commercial and Clinical Progress for Facilitating Long-Term Growth
May 12, 2026
TriSalus Life Sciences Announces Launch of PREDICTT Clinical Trial Evaluating Pressure-Enabled Drug Delivery in Liver Tumors
May 4, 2026
TriSalus Life Sciences to Host First Quarter 2026 Financial Results Conference Call
April 28, 2026
TriSalus Life Sciences to Present New Data at the 2026 Society of Interventional Radiology Annual Scientific Meeting
April 9, 2026
TriSalus Life Sciences Appoints Richard Marshall, M.D., as Chief Medical Officer
April 7, 2026
TriSalus Life Sciences Announces Publication Demonstrating Enhanced Delivery and Immune Activation with Nelitolimod Delivered with Pressu...
March 18, 2026
TriSalus Life Sciences Reports Fourth Quarter and Year-End 2025 Results and Reaffirms 2026 Revenue Guidance
March 5, 2026
TriSalus Life Sciences to Host Fourth Quarter 2025 Financial Results Conference Call
February 25, 2026
TriSalus Life Sciences Announces Pricing of $40.0 Million Public Offering
February 20, 2026
TriSalus Life Sciences Proposes Public Offering
February 19, 2026
TriSalus Life Sciences Appoints Veteran Healthcare Investor Michael Stansky to its Board of Directors
February 9, 2026
TriSalus Life Sciences Announces Preliminary Fourth Quarter and Full-Year 2025 Results and 2026 Revenue Guidance
January 12, 2026
TriSalus Life Sciences to Host Virtual KOL Event to Discuss the TriNav Infusion System for the Treatment of Symptomatic Thyroid Disease o...
December 4, 2025
TriSalus Life Sciences Launches TriNav® XP Infusion System to Expand Options for Pressure-Enabled Drug Delivery™
November 18, 2025
TriSalus Life Sciences Reports Third Quarter 2025 Results and Reaffirms 2025 Revenue Guidance
November 13, 2025
TriSalus Life Sciences to Participate in Upcoming Investor Conferences
November 11, 2025
TriSalus Life Sciences to Host Virtual KOL Event to Discuss the TriNav Infusion System for the Treatment of Uterine Fibroids on November ...
November 10, 2025
TriSalus Life Sciences to Host Third Quarter 2025 Financial Results Conference Call
October 30, 2025
TriSalus Life Sciences to Participate in Upcoming September Investor Conferences
August 28, 2025
TriSalus Life Sciences Reports Second Quarter 2025 Results and Reiterates 2025 Guidance
August 12, 2025
TriSalus Life Sciences Announces Publication of Safety and Efficacy Results for a Novel Pressure-Enabled Thyroid Embolization Technique
August 11, 2025
TriSalus Life Sciences to Participate in the Canaccord Genuity 45th Annual Growth Conference
July 30, 2025
TriSalus Life Sciences to Host Second Quarter 2025 Financial Results Conference Call
July 29, 2025
TriSalus Life Sciences Announces Expiration and Results of Exchange Offer and Consent Solicitation Relating to Series A Convertible Prefe...
July 24, 2025
TriSalus Life Sciences Announces Commencement of Exchange Offer and Consent Solicitation Relating to Series A Convertible Preferred Stock...
June 23, 2025
TriSalus Life Sciences Announces the Launch of the TriNav FLX Infusion System
June 4, 2025
TriSalus Life Sciences Announces Chief Financial Officer Transition With Appointment of David B. Patience
May 30, 2025
TriSalus Life Sciences Reports First Quarter 2025 Results and Provides Updated 2025 Guidance
May 15, 2025
TriSalus Life Sciences to Host First Quarter 2025 Financial Results Conference Call
May 12, 2025
TriSalus Life Sciences Announces $22.0 Million Private Placement Preliminary Q1 2025 Unaudited Financial Results
April 30, 2025
TriSalus Life Sciences Reports Q4 and Full Year 2024 Financial Results and Provides Business Update
March 27, 2025
TriSalus Life Sciences Announces New CMS HCPCS Code for TriNav® Infusion System Mapping
March 26, 2025
TriSalus Life Sciences® Announces That Its Researchers Received Two JVIR Top Paper Awards for the Publication of "Intra-arterial Pressure...
March 6, 2025
TriSalus Life Sciences® Announces That Its Researchers Received Two JVIR Top Paper Awards for the Publication of “Intra-arterial Pressure...
March 6, 2025
TriSalus Life Sciences Announces Drawdown of $10 Million Tranche Under Credit Agreement with OrbiMed
February 3, 2025
TriSalus Life Sciences Announces Key Appointments to Board of Directors
February 3, 2025
TriSalus Life Sciences Announces Preliminary Q4 and Full Year Unaudited 2024 Financial Results and Conference Call
January 23, 2025
TriSalus Life Sciences® Announces Publication of Pre-Clinical Data Demonstrating Improved Delivery of Embospheres® to Liver Tumors using ...
January 9, 2025
TriSalus Announces Leadership Changes
January 8, 2025
TriSalus Reports Q3 2024 Financial Results and Provides Business Update
November 14, 2024
TriSalus Life Sciences® Forms Strategic Partnership with Geo-Med, LLC to Expand Access of the TriNav® Infusion System to U.S. Veterans wi...
November 11, 2024
TriSalus Life Sciences Launches TriNav® LV Infusion System and TriGuide™ Guiding Catheters, Expanding Portfolio of PEDD™ Devices for Impr...
November 7, 2024
TriSalus Life Sciences to Host Third Quarter 2024 Financial Results Conference Call
October 31, 2024
TriSalus Life Sciences to Participate in the 2024 Maxim Healthcare Virtual Summit
October 14, 2024
TriSalus Life Sciences Announces Appointment of Riad Salem, M.D., to its Scientific Advisory Board
September 26, 2024
TriSalus Announces Journal of Vascular and Interventional Radiology Publication of Data that Demonstrate Improved Therapeutic Delivery of...
September 23, 2024